Euclidean Capital as of Dec. 31, 2020
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 10 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | 54.4 | $257M | 4.2M | 61.51 | |
| Ngm Biopharmaceuticals (NGM) | 13.4 | $63M | 2.1M | 30.30 | |
| Oric Pharmaceuticals (ORIC) | 10.0 | $47M | 1.4M | 33.85 | |
| Denali Therapeutics (DNLI) | 5.7 | $27M | 324k | 83.76 | |
| Foghorn Therapeutics (FHTX) | 5.4 | $26M | 1.3M | 20.27 | |
| Constellation Pharmceticls I | 3.4 | $16M | 554k | 28.80 | |
| Alector (ALEC) | 3.1 | $15M | 981k | 15.13 | |
| Rapt Therapeutics (RAPT) | 3.1 | $15M | 736k | 19.75 | |
| Revolution Medicines (RVMD) | 0.8 | $3.7M | 93k | 39.59 | |
| First Financial Ban (FFBC) | 0.6 | $3.0M | 174k | 17.53 |
